The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.

Acad Radiol

The Center of PET/CT, The Affiliated Tumor Hospital of Harbin Medical University, 150 Haping Road, Nangang District, 150081, Harbin, Heilongjiang Province, China. Electronic address:

Published: May 2016

Rationale And Objectives: The aim of this study was to evaluate the prognostic value of 18-fluoro-2-deoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) volume-metabolic combined parameters in patients with cervical carcinoma.

Materials And Methods: We retrospectively reviewed 91 consecutive patients' whole-body FDG-PET/CT images, and further measured and calculated FDG PET/CT volume-metabolic parameters, including cervical metabolic tumor volume (CMTV), cervical total lesion glycolysis (CTLG), whole-body metabolic tumor volume (WB-MTV), whole-body total lesions glycolysis (WB-TLG). The prognostic value of these tumor volume-metabolic measures was assessed by Cox Proportional Hazard Regression Analysis.

Results: The overall survival (OS) was 88.8% for patients with low CMTV (≤53.75 mL) and 45.5% for those with high CMTV (>53.75 mL), respectively (P < 0.01, 95% confidence interval). Univariate analysis showed that CMTV and CTLG were significant prognostic factors for OS, in addition to International Federation of Gynecology and Obstetrics (FIGO) stage, age, lymphadenopathy, and maximum standardized uptake value (SUVmax) (P < 0.05 for all). On multivariate analysis, CMTV remained significant for OS, in addition to FIGO stage (P < 0.05 for all). CMTV remains as prognostic factor for OS regardless of patients' FIGO stages (P < 0.05). In patients in the metastatic diseases group, univariate and multivariate analyses demonstrated that CMTV, WB-MTV, and WB-TLG were independent prognostic factors for OS (P < 0.05 for all).

Conclusion: CMTV, WB-MTV, and WB-TLG are reliable prognostic factors for patients with cervical carcinoma and should be included in FDG-PET/CT reports to guide referral clinicians for risk-adapted therapies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2016.01.001DOI Listing

Publication Analysis

Top Keywords

volume-metabolic combined
8
combined parameters
8
18f-fdg pet/ct
8
pet/ct volume-metabolic
8
metabolic tumor
8
tumor volume
8
volume-metabolic
4
parameters 18f-fdg
4
pet/ct help
4
help predict
4

Similar Publications

Update on Gastrointestinal Stromal Tumors for Radiologists.

Korean J Radiol

August 2017

Department of Imaging, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Department of Radiology, Brigham and Women's Hospital, Boston, MA 02115, USA.

The management of gastrointestinal stromal tumors (GISTs) has evolved significantly in the last two decades due to better understanding of their biologic behavior as well as development of molecular targeted therapies. GISTs with exon 11 mutation respond to imatinib whereas GISTs with exon 9 or succinate dehydrogenase subunit mutations do not. Risk stratification models have enabled stratifying GISTs according to risk of recurrence and choosing patients who may benefit from adjuvant therapy.

View Article and Find Full Text PDF

The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.

Acad Radiol

May 2016

The Center of PET/CT, The Affiliated Tumor Hospital of Harbin Medical University, 150 Haping Road, Nangang District, 150081, Harbin, Heilongjiang Province, China. Electronic address:

Rationale And Objectives: The aim of this study was to evaluate the prognostic value of 18-fluoro-2-deoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) volume-metabolic combined parameters in patients with cervical carcinoma.

Materials And Methods: We retrospectively reviewed 91 consecutive patients' whole-body FDG-PET/CT images, and further measured and calculated FDG PET/CT volume-metabolic parameters, including cervical metabolic tumor volume (CMTV), cervical total lesion glycolysis (CTLG), whole-body metabolic tumor volume (WB-MTV), whole-body total lesions glycolysis (WB-TLG). The prognostic value of these tumor volume-metabolic measures was assessed by Cox Proportional Hazard Regression Analysis.

View Article and Find Full Text PDF

Dose-response effect of walking exercise on weight loss. How much is enough?

Int J Obes Relat Metab Disord

November 2002

Department of Exercise and Sport Science, School of Education, University of Miami, Florida 33124-2040, USA.

Objective: Exercise is the cornerstone of behavioral weight loss programs. The total volume of exercise needed to both promote weight loss and elicit health benefits has not been sufficiently investigated. The aim of this study was to examine the effects of two different volumes of walking 'metabolic fitness' exercise prescriptions, in combination with a low-fat, ad libitum diet (LFAL) on weight loss and additional modifiable health-related variables (HRV) in an ethnically diverse sample of overweight premenopausal women.

View Article and Find Full Text PDF

Syncope.

Phys Sportsmed

May 1992

In brief Syncopal episodes are usually benign, but some causes can be life-threatening. The differential diagnosis is extensive and includes vasovagal reaction, decreased intravascular volume, metabolic disorders, cardiac disorders, medication use and abuse, Valsalva maneuver, and intracranial conditions. A detailed account of the event and a medical history direct the workup.

View Article and Find Full Text PDF

The paper is concerned with the results of the studies on corticosteroid kinetics (secretion rate, distribution volume, metabolic blood clearance, mean daily blood cortisol content and excretion of free hormone with urine) in 44 patients suffering from Icenko-Cushing's disease, treated with chloditane and/or chloditane combined with massive reserpine doses. The above parameters increased in Icenko-Cushing's disease during clinical remission after chloditane or chloditane and reserpine treatment. No differences between effects on glucocorticoid secretion and metabolism after the treatment with chloditane or chloditane in combination with high reserpine doses were recorded.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!